renal cell carcinoma

5 Reasons Exelixis's Cabometyx Is Set To Be The Next Blockbuster Opportunity
Seeking Alpha
Thu, 11/10/16 - 10:59 am
Exelixis
Cabometyx
renal cell carcinoma
These 3 Little Biotechs Just Scored Big
Motley Fool
Tue, 10/11/16 - 09:33 pm
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
AVEO Collaborates With Bristol-Myers Squibb for RCC Drug
Investopedia
Fri, 09/23/16 - 09:43 am
Aveo Pharmaceuticals
Bristol-Myers Squibb
renal cell carcinoma
tivozanib
Exelixis, Inc. Gets Some ASCO Love
Motley Fool
Tue, 06/7/16 - 11:16 am
Exelixis
ASCO 2016
Cabometyx
renal cell carcinoma
Exelixis Rises on Positive Late-Stage Trial Results
24/7 Wall St
Mon, 02/1/16 - 11:17 pm
Exelixis
cabozantinib
renal cell carcinoma
clinical trials
FDA Grants Breakthrough Therapy Designation to Exelixis’ Cabozantinib for the Treatment of Renal Cell Carcinoma in Patients Who Received One Prior Therapy
Yahoo
Mon, 08/24/15 - 11:26 am
FDA
Exelixis
breakthrough therapies
renal cell carcinoma
cabozantinib
Tivozanib Is the Gift That Keeps On Giving For Aveo
24/7 Wall St
Thu, 06/4/15 - 08:14 pm
tivozanib
Aveo Oncology
renal cell carcinoma
IPO Preview: Argos Therapeutics
Seeking Alpha
Fri, 02/7/14 - 09:30 am
IPOs
Argos Therapeutics
AGS-003
renal cell carcinoma
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Fierce Biotech
Tue, 12/31/13 - 11:42 am
Argos
IPOs
Dendreon
AGS-003
personalized medicine
renal cell carcinoma
Merck and GlaxoSmithKline partner to evaluate renal cell carcinoma regimen
The Fly on the Wall
Wed, 12/18/13 - 09:16 am
renal cell carcinoma
Merck
GSK
MK-3475
pazopanib
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
Yahoo
Thu, 05/23/13 - 10:01 am
Lpath
Asonep
renal cell carcinoma
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
AVEO: Here's Looking At You, FDA
Seeking Alpha
Sun, 05/5/13 - 10:48 am
Aveo Pharmaceuticals
tivozanib
renal cell carcinoma
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Wed, 04/24/13 - 10:19 am
Aveo Pharmaceuticals
FDA
tivozanib
GSK
Onyx
Pfizer
renal cell carcinoma
Roche
Why We Expect The FDA To Approve Aveo's Tivozanib
Seeking Alpha
Tue, 04/16/13 - 10:52 am
FDA
tivozanib
Aveo Pharmaceutical
renal cell carcinoma
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Delcath
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Chemosat
melanoma
metastatic melanoma
Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma?
Seeking Alpha
Thu, 03/14/13 - 10:51 am
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
AVEO: Final Overall Survival Results From The TIVO­1 Study
Seeking Alpha
Thu, 02/14/13 - 11:18 am
Aveo Pharmaceutical
tivozanib
renal cell carcinoma
Pfizer's Torisel drug fails in a combination study
Yahoo/Reuters
Fri, 08/10/12 - 10:03 am
Torisel
Pfizer
renal cell carcinoma

Pages